Terahertz and far-infrared synchrotron spectroscopy and global modeling of methyl mercaptan, CH3(32)SH.

In this work, terahertz and Fourier transform far-infrared (FTFIR) synchrotron spectra of methyl mercaptan, CH(3)SH, have been investigated in order to provide new laboratory information for enhanced observations of this species in interstellar molecular clouds and star-forming regions. Like its methanol cousin, methyl mercaptan has particularly rich spectra associated with its large-amplitude internal rotation that extend throughout the THz and FIR regions. We have recorded new spectra for CH(3)SH from 1.1-1.5 and 1.790-1.808 THz at the University of Cologne as well as high-resolution FTFIR synchrotron spectra from 50-550 cm(-1) at 0.001 cm(-1) resolution on the far-IR beam-line at the Canadian Light Source. Assignments are reported for rotational quantum numbers up to J ≈ 40 and K ≈ 15, and torsional states up to v(t) = 2 for the THz measurements and v(t) = 3 for the FTFIR observations. The THz and FTFIR measurements together with literature results have been combined in a global analysis of a dataset comprising a total of 1725 microwave and THz frequencies together with ~18000 FTFIR transitions, ranging up to v(t) = 2 and J(max) = 30 for MW∕THz and 40 for FTFIR. The global fit employs 78 torsion-rotation parameters and has achieved a weighted standard deviation of ~1.1. A prediction list (v(t) ≤ 2, J ≤ 45 and K ≤ 20) has been generated from the model giving essentially complete coverage of observable CH(3)(32)SH transitions within the bandwidths of major new astronomical facilities such as HIFI (Heterodyne Instrument for the Far Infrared) on the Herschel Space Observatory, ALMA (Atacama Large Millimeter Array), SOFIA (Stratospheric Observatory For Infrared Astronomy) and APEX (Atacama Pathfinder Experiment) to close to spectroscopic accuracy.

Artefactually-normal automated platelet counts due to malaria-infected RBC.

Protein aggregates, red cell or white cell fragments are known to interfere with platelet counts in automated blood analysers, both by aperture impedance and optical technologies. When a falsely high value is suspected, interference by pseudo-platelet particles can be confirmed by systematic examination of stained blood films. The method that best avoids these sources of interference is the reference, immunological platelet count. We describe a case of treated malaria with a false normal platelet count. The blood smear revealed small red cells, infected by trophozoites of Plasmodium falciparum, that interfered with the platelet count. The Cell Dyn 4000 shows different patterns of interference by infected red cells in its impedance and optical counts, and thrombocytopenia was suspected immediately. This was confirmed by a phase-contrast microscopic platelet count.

A case-control study of sporadic infection with O157 and non-O157 verocytotoxin-producing Escherichia coli.

Potential risk factors for sporadic verocytotoxin-producing Escherichia coli (VTEC) infection in Belgium were investigated in a matched case-control study. Thirty-seven cases, 8 infected with O157 VTEC strains (all eaeA-positive), 29 with non-O157 VTEC strains (13 eaeA-positive and 16 eaeA-negative) and 69 matched controls were interviewed. In a conditional logistic regression analysis, consumption of fish appeared to be a risk factor for infection (adjusted odds ratio (OR) 3.25, P = 0.04). Contact with dogs (OR 0.27, P = 0.04) and consumption of shellfish (OR 0.19, P = 0.05) showed a negative association, corresponding to a decrease in risk. These findings might be explained if low level environmental exposure to VTEC induces protective immunity. Eating raw meat, a frequent habit in Belgium, or hamburgers, or eating in a fast-food restaurant was not more frequently reported by cases than controls. The exposures causing sporadic infections with VTEC, in particular non-O157 strains, may be very different from those which led to outbreaks, and may account for more cases overall.

The use of the Penlon Nuffield 200 in a monoplace hyperbaric oxygen chamber. An evaluation of its use and a clinical report in two patients requiring ventilation for carbon monoxide poisoning.

We modified a Penlon Nuffield 200 for use in a monoplace hyperbaric oxygen chamber by feeding back the chamber pressure to the reducing valve of the Nuffield 200. This provides a compensating mechanism, allowing the ventilator to deliver adequate tidal volumes at pressures of up to 3 atmospheres. We report the laboratory testing of the ventilator and our experience of ventilating two patients with carbon monoxide poisoning. Although compensation is not complete the modification is adequate for short-term clinical use in patients in whom the airway is compromised but who need hyperbaric oxygen therapy.